Bovie Medical Corporation to Present at the Sidoti & Company Fall 2018 Investor Conference
September 11 2018 - 4:05PM
Business Wire
Bovie Medical Corporation (NYSEMKT:BVX) (the “Company”),
a maker of medical devices and supplies and the developer of
J-Plasma®, a patented surgical product marketed and sold under the
Renuvion™ Cosmetic Technology brand in the cosmetic surgery market,
today announced that management will participate in the Sidoti
& Company Fall 2018 Investor Conference at the Grand Hyatt in
New York, New York. Management will present to investors on
Thursday, September 27 at 8:00 a.m. Eastern Time.
A live audio webcast of the presentation will be provided under
the ‘Company Events’ section of the Bovie Medical investor
relations website at
http://www.boviemedical.com/investor_relations/. An archive of the
webcast will be available for replay following the conferences.
About Bovie Medical
Corporation:
Bovie Medical Corporation is a leading maker of medical devices
and supplies as well as the developer of J-Plasma® technology
(marketed and sold under the Renuvion™ Cosmetic Technology brand in
the cosmetic surgery market), a patented plasma-based surgical
product for cutting, coagulation and ablation of soft tissue.
J-Plasma technology utilizes a helium ionization process to produce
a stable, focused beam of plasma that provides surgeons with
greater precision, and minimal invasiveness. The Company also
leverages its expertise through original equipment manufacturing
(OEM) agreements with other medical device manufacturers. For
further information about the Company and its products, please
refer to the Bovie Medical Corporation website
at www.boviemedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180911005487/en/
Investor Relations
Contact:Westwicke Partners on behalf of Bovie
Medical CorporationMike Piccinino,
CFA443-213-0500investor.relations@boviemed.com
Bovie (AMEX:BVX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Bovie (AMEX:BVX)
Historical Stock Chart
From Apr 2023 to Apr 2024